Diaceutics PLC
Diaceutics PLC (DIUXF) Revenue
Annual & quarterly revenue history · segment & region breakdown
DIUXF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsDiaceutics PLC trailing twelve-month (TTM) revenue is $0.07B, an increase of 19.51% year-over-year from $0.04B in FY2025.
Revenue trend
2025 – 2015 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.04B | +$0.01B | +19.51% |
| 2024-12-31 | $0.03B | +$0.01B | +35.69% |
| 2023-12-31 | $0.02B | +$0.00B | +21.51% |
| 2022-12-31 | $0.02B | +$0.01B | +39.88% |
| 2021-12-31 | $0.01B | +$0.00B | +9.82% |
| 2020-12-31 | $0.01B | -$0.00B | -5.55% |
| 2019-12-31 | $0.01B | +$0.00B | +29.59% |
| 2018-12-31 | $0.01B | +$0.00B | +40.74% |
| 2017-12-31 | $0.01B | +$0.00B | +60.63% |
| 2016-12-31 | $0.00B | +$0.00B | +228.33% |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Diaceutics PLC receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Diaceutics PLC reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in GBP.
Data sourced from Diaceutics PLC's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
DIUXF revenue · 4 questionsDIUXF's trailing twelve-month (TTM) revenue is $0.07B. That is an increase of 19.51% year-over-year from $0.04B in FY2025.
▸ Source: FMP · Diaceutics PLC SEC filings · GAAP · Diaceutics PLC SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026